Active Ingredient History

NOW
  • Now
Lincomycin (LINCOCIN®) is an antibiotic produced by Streptomyces lincolnensis (Streptomycetaceae family). It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections. Lincomycin (LINCOCIN®) inhibits protein synthesis in susceptible bacteria by binding to the 50S subunits of bacterial ribosomes and preventing peptide bond formation upon transcription. It is usually considered bacteriostatic, but may be bactericidal in high concentrations or when used against highly susceptible microorganisms.   NCATS

  • SMILES: O.Cl.CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O
  • InChIKey: LFZGYTBWUHCAKF-DCNJEFSFSA-N
  • Mol. Mass: 461.02
  • ALogP: -0.86
  • ChEMBL Molecules:
More Chemistry

Drug Pricing (per unit)

United States

$10.8200 - $87.9400

Australia

$13.3010
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

cillimycin | jiemycin | lcm | lincocin | lincomycin | lincomycin a | lincomycine | lincomycin hcl | lincomycin hydrochloride | medoglycine | u-10149

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue